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Objectives. This study was done to evaluate three bedside tests in discriminating visceral pain from somatic pain among women
with chronic pelvic pain. Study Design. The study was an exploratory cross-sectional evaluation of 81 women with chronic pelvic
pain of 6 or more months’ duration. Tests included abdominal cutaneous allodynia (aCA), perineal cutaneous allodynia (pCA),
abdominal and perineal myofascial trigger points (aMFTP) and (pMFTP), and reduced pain thresholds (RPTs). Results. Eighty-
one women were recruited, and all women provided informed consent. There were 62 women with apparent visceral pain and
19 with apparent somatic sources of pain. The positive predictive values for pelvic visceral disease were aCA-93%, pCA-91%,
aMFTP-93%, pMFTP-81%, and RPT-79%. The likelihood ratio (+) and 95% C.I. for the detection of visceral sources of pain
were aCA-4.19 (1.46, 12.0), pCA-2.91 (1.19, 7.11), aMTRP-4.19 (1.46, 12.0), pMFTP-1.35 (0.86, 2.13), and RPT-1.14 (0.85, 1.52),
respectively. Conclusions. Tests of cutaneous allodynia, myofascial trigger points, and reduced pain thresholds are easily applied
and well tolerated. The tests for cutaneous allodynia appear to have the greatest likelihood of identifying a visceral source of pain
compared to somatic sources of pain.
1.Introduction
Chronic pelvic pain is a complex disorder that is poorly
understood. Chronic pelvic pain is deﬁned as pain of six
or more months’ duration that is situated in the abdomen,
groin or lower back [1]. The use of diagnostic imaging
techniques such as ultrasound, CT scanning, and magnetic
resonance techniques has been helpful for many gynecologi-
calconditions,butcommonlythetestsarenormaldespitethe
presenceof severechronic pain [2,3].Womensuﬀeringfrom
chronic pelvic pain are often personally challenged because
of the absence of evidence to support their complaints of
severe pain [4, 5]. Recognized causes of chronic pelvic pain
include visceral conditions such as endometriosis, pelvic
inﬂammatory disease, and pelvic adhesions and somatic
conditions such as lower genital tract surgery or vehicular
trauma to the pelvis [6, 7]. In many cases the diﬀerentiation
betweenvisceralandsomaticreasonsisobvious,butinsome,
the distinction is not evident. This can lead to situations
where investigations and surgery are repeated and in some
cases extensively.
Pain arising from the pelvic organs of the uterus,
fallopian tubes, ovaries, ureter, kidney pelvis, bladder, and
rectumisdeﬁnedasvisceralinnature.Suchpainisduetothe
presence of visceral nociceptors present in the various organs
of the female pelvis [8]. The origins of understanding of the
physiology extend back to a signiﬁcant period of time [9].
The concepts of referred visceral pain to a speciﬁc cutaneous
location and that an irritable focus in certain tissues could
be responsible for such localization extend to many years
[10, 11]. Notably, stimulation of the ureter or the pelvis of
the kidney was found to cause a contraction of the muscles
of the abdominal wall on the stimulated side and remain
contracted for a period of time [12]. Stimulation of visceral
tissues causes a viscerosomatic reﬂex, and there is evidence
this can be mediated from sympathetic eﬀerent activity as2 Pain Research and Treatment
the local pain of trigger points in the muscle is not only
reduced by the administration of local anesthetic into the
trigger point but can be reduced as well as by a sympathetic
blockade [13, 14]. Visceral pain was also found to reduce
cutaneous pain thresholds to thermal stimuli in the referred
area [15].
The complexity of pain in the female reproductive
system, particularly the relationship of the referral of pain
throughviscerosomaticprocesses,hasrecentlybeenreviewed
by Giamberardino [16]. As the visceral aﬀerents are greatly
outnumbered by somatic aﬀerents, there is considerable
merging of signals which makes the speciﬁcity of organ of
origin a complex message for the central nervous system.
This means that pain originating from pelvic organs may
not be identiﬁed with accuracy [17, 18]. In studies of
biliary disease, the presence of visceral aﬀerents became
apparent through transmission of pain from the gallblad-
der to the spinal cord which, when severe or repetitive,
produce changes in the referred dermatomes [19]. Under
these circumstances, changes occurred in the right-upper
quadrant including cutaneous allodynia, muscle tenderness,
and reduced pain thresholds in the subcutaneous and
muscular tissues of the right upper quadrant [19]. There was
a direct positive correlation between the number of colicky
episodes and the degree of pain threshold reduction. The
current study of the interaction of visceral disease and pelvic
pain is based on these important previous investigations,
particularly those evaluating biliary disease.
The relationship of visceral disease to areas of muscle
tenderness has a long history [10, 11, 20]. Extrapelvic
examples of the development of myofascial trigger points
from visceral disease include biliary, cardiac, and renal
causes[21–23].Morespeciﬁcreferencestothepelvicdiseases
include endometriosis and interstitial cystitis [23, 24].
The speciﬁc research question was an exploratory eval-
uation of the ability of simple bedside tests of cutaneous
allodynia, myofascial pain, and reduced pain thresholds to
diﬀerentiate women with visceral and somatic conditions
associated with their chronic pelvic pain [25].
2. Methods
This was a cross-sectional study that studied the clinical
assessment of women with three diagnostic tests. Eighty-
one women referred by a family physician or a gynecologist
for complaints of chronic pelvic pain were included in
the study. The date of entry was the date of approval of
ethics application at The University of Calgary which was 13
November, 2009. The date of completion was April 8, 2011.
Women were approached to enter the study during a clinical
consultationforthemanagementofchronicpain.Allwomen
approached agreed to the study with the exception of one
who declined for no given reason. The operational deﬁnition
of visceral disease as a cause of the woman’s chronic pelvic
pain was pain that clinically appeared to be originating
from visceral tissues. This was based on the clinical history,
physical examination, referral information, and available
documentation from the health records of the Calgary
Health Region of Alberta Health Services. Women who were
identiﬁed as having somatic pain did not have a history of
visceral disease but did have prior lower genital tract surgery,
lower genital tract obstetrical trauma, or musculoskeletal
disorders of the pelvic bones from prior motor vehicle
accidents. For this study the individual therapies for pain
were not collected.
The clinical testing was undertaken contemporaneously
with the pain evaluation and collection of all relevant
medical history. The testing was done by a single unblinded
observer. All women complained of chronic pelvic pain for
more than six months. Women were selected on the basis of
convenience given the availability of clinic time. The study
was approved by the ethics committee of the University
of Calgary. All women provided informed consent for the
project.
Testing for cutaneous allodynia involved the use of a
cotton-tipped culture stick as previously demonstrated [26]
and validated [27]. The culture stick is drawn down from
the upper abdomen into the area identiﬁed as painful by
the woman. In the presence of cutaneous allodynia there is
a sharply demarcated area in which this sensation goes from
nonpainful to a painful sensation. The area can be variable
in size, from dime-sized areas on one or both sides of the
lower quadrants to broad expanses of the lower abdomen.
TheusuallocationisintheregionofthedermatomesofT12-
L1 located centrally in the abdomen. The same approach is
undertaken on the perineum by drawing the cotton-tipped
culture stick across the buttocks in a horizontal fashion to
identify mainly the S3 dermatome. Preliminary studies of
the validity have demonstrated blinded interrater reliability
of 98%.
Within the areas of cutaneous allodynia, one can appre-
ciate increased muscle tone and myofascial trigger points
[24, 25]. The examination for myofascial trigger points has
been validated [28]. These are conﬁrmed by an examination
of the abdominal wall and perineum within the area of
cutaneousallodyniainwhichasmallnodulecanbepalpated.
The patient often will direct the examiner in detecting the
painful area. When this nodule is pressed, it causes severe
pain with referral of pain into the back, legs, chest, and pelvis
[29]. The sensation of the pain has commonly the same
characteristic as the chronic pain being experienced. When
the pressure is released, the pain resolves. The areas tested
for this study included the right- and left-upper abdominal
andtheright-andleft-lowerabdominalquadrants.Inalmost
all cases, the myofascial trigger points were identiﬁed in
the right- and/or left-lower quadrants near the junction of
the external oblique and rectus abdominus muscles. As many
women with chronic pelvic pain have diﬃculty associated
with sexual relations, owing to myofascial dysfunction on
the perineum, we also included testing of the presence of a
trigger point on the perineal body.
Pain threshold evaluation involved the use of the Von
Frey electroanesthesiometer (IITC Life Science). This test
has been validated for the assessment of pain [30]. It was
initially applied to the deltoid muscle as a reference point
or internal control. Pressure of 100g that did not produce
pain was taken as a negative test on the deltoid and other
areas. Measurements of pain threshold were then taken inPain Research and Treatment 3
Table 1: Demographics of women with chronic pelvic pain.
Diagnosis Age∗ Gravida∗∗ Para∗∗ Duration∗ Laparoscopy∗∗ Laparotomy
Visceral N 62 60 60 62 61 59
Mean 32.3 0.8 0.6 4.8 1.7 0.4
Median 30.5 0.0 0.0 3.0 1.0 0.0
Std. error of mean 1.2 0.2 0.1 0.6 0.3 0.1
Std. deviation 9.4 1.3 1.0 4.3 2.7 0.7
Somatic N 19 19 19 19 16 16
Mean 39.4 2.0 1.6 3.0 0.3 0.2
Median 33.0 2.0 2.0 2.0 0.0 0.0
Std. error of mean 2.9 0.3 0.3 0.6 0.2 0.1
Std. deviation 12.4 1.5 1.3 2.6 0.8 0.4
∗P<0.01; ∗∗P<0.001.
the right-upper and right-lower abdominal quadrants and
the left-upper and left-lower abdominal quadrants and the
perineal body which is located on the perineum just distal to
the hymen on the posterior fourchette. On the perineum, the
algometer was applied to the aﬀected muscle by applying the
instrument to a sterile culture stick. In all testing the pressure
was gradually applied to the aﬀected area until the woman
identiﬁed a painful sensation or until a maximum of 100
g pressure was obtained. Pain thresholds lower than 100g
were identiﬁed as demonstrating reduced pain thresholds.
The measurement was then calculated as a percentage of the
deltoid measurement.
The presence or absence of cutaneous allodynia, myofas-
cial dysfunction, and reduced pain thresholds was evaluated
in relation to the clinical diagnosis to determine the sensitiv-
ity, speciﬁcity, positive predictive values, negative predictive,
likelihood ratios, and odds ratios of the tests. Categorical
results were evaluated with contingency methods and non-
normally distributed variables were compared using the
Mann Whitney U test. Statistical analysis was done using
SPSS. Diagnostic test properties were evaluated using tests
for sensitivity, speciﬁcity, positive predictive value (PPV),
negative predictive value (NPV), likelihood ratio, and odds
ratio with 95% conﬁdence intervals (95% C.I.) [31].
3. Results
A total of 81 women who were complaining of pelvic pain
for at least six months were included in the study. Of the
81 women, 62 were identiﬁed as having prior or current
visceral disease and 19 were identiﬁed as having somatic
causes of pain. Of the women with visceral pain, the fol-
lowing conditions were identiﬁed: endometriosis-36; pelvic
inﬂammatory disease-2; adhesions-5; interstitial cystitis-1;
dysmenorrhea-11; ovarian cyst removal-4, ﬁbroid-2; tubal
ligation-1. The 19 women with somatic causes of pain had
clinical histories indicating trauma to the lower genital tract
or pelvis from surgery or motor vehicle accidents. Four
women were identiﬁed as having both visceral and somatic
causes of pain.
Themeanageoverallofthewomenwas33.9 ±1.2(SEM)
years. They had previous gravidity status of 1.06 ± 0.16
and parity of 0.82 ± 0.13. The mean duration of pain was
4.3 ± 0.45 years. Women with visceral pain were younger
(P<0.01), had fewer pregnancies (P<0.001), and reported
a longer duration of pain (P<0.01) when compared to
women with somatic pain (Table 1). Women with visceral
disease had a greater number of prior laparoscopies (P<
0.001) but similar number of laparotomies when compared
to women with somatic pain (Table 1).
The diagnostic test results are presented in Table 2.
Abdominal and perineal cutaneous allodynia and abdom-
inal myofascial trigger points were found to signiﬁcantly
discriminate visceral from somatic sources of pain (P<
0.001). Perineal myofascial trigger points and reduced
pain thresholds did not discriminate visceral from somatic
sources of pain. The evaluation of likelihood and odds ratios
in relation to the use of these tests to detect a visceral
source of pain is presented in Table 3. The likelihood and
the odds ratios of a positive ﬁnding of abdominal and
perineal cutaneous allodynia and abdominal trigger points
signiﬁcantly indicated a positive identiﬁcation of a visceral
source of pain compared to a somatic source of pain (P<
0.001) (Table 3).
A comparison of the numeric reduction in pain thresh-
olds identiﬁed using the Von Frey electroanesthesiometer
demonstrated signiﬁcantly lower pain thresholds in the
right- and left-lower quadrants of women with visceral pain
compared to women with somatic pain (P<0.05) (Table 4).
There were no diﬀerences in mean pain thresholds in the
deltoid region, upper abdominal quadrants, or perineum.
4. Comment
This was a preliminary evaluation of three simple tests that
can be used at the bedside for the evaluation of women with
chronicpelvicpain.Thetestsarenotuniqueandarebasedon
historicandcontemporaryassessmentsofvisceraldisease[2–
9]. The discriminating factor was the clinical assessment in
the determination of allocation to either visceral or somatic
sources of pain.
Underthesecircumstances,womenwithanapparentvis-
ceralsource ofpain wereyounger, hadfewerpregnancies and
alongerdurationofpain,andmorefrequentlydemonstrated4 Pain Research and Treatment
Table 2: Sensitivity, speciﬁcity, positive and negative predictive
values of cutaneous allodynia, myofascial trigger points, and
reduced pain thresholds among women with visceral and somatic
pain.
Visceral Somatic
Abdominal
cutaneous
allodynia
Yes 41 3 Sensitivity 0.66
Speciﬁcity 0.84
No 21 16 PPV 0.93
NPV 0.43
P<0.001
Perineal
cutaneous
allodynia
Yes 38 4 Sensitivity 0.61
Speciﬁcity 0.79
No 24 15 PPV 0.91
NPV 0.38
P = 0.001
Abdominal
trigger
points
Yes 41 3 Sensitivity 0.66
Speciﬁcity 0.84
No 21 16 PPV 0.93
NPV 0.43
P<0.001
Perineal
trigger
points
Yes 44 10 Sensitivity 0.70
Speciﬁcity 0.47
No 18 9 PPV 0.81
NPV 0.33
NS
Reduced
pain
thresholds
Yes 52 14 Sensitivity 0.83
Speciﬁcity 0.26
No 10 5 PPV 0.79
NPV 0.33
NS
abdominal and perineal cutaneous allodynia and abdominal
trigger points than women with an apparent somatic source
of pain. Although there was a similar trend for reduced
pain thresholds, these categorical diﬀerences did not attain
statistical signiﬁcance. However, the actual measures of pain
thresholdreductionweregreateramongwomenwithvisceral
disease in the right- and left-lower quadrants. The actual
mechanism(s) associated with these changes is not known
conclusively but likely relates to the phenomenon of central
sensitization in the dorsal horns of the spinal cord [32–34].
These ﬁndings are in part consistent with the validated
model of biliary disease of Giamberardino et al. and extend
our understanding of visceral aﬀerents to the problems of
chronic pelvic pain [35, 36]. Although the biliary studies
were able to demonstrate a relationship of the number of
colickyepisodes,inthisstudytherewasnorelationshipnoted
b e t w e e nd u r a t i o no fp a i na n dt h ep r e s e n c ea n ds e v e r i t yo f
pain threshold reduction [37]. The lack of a reduction in
pain thresholds in this study possibly reﬂects the Von Frey
electroanesthesiometer is less sensitive than the electrical
stimulationmethodsofGiamberardino’sstudy.Alternatively,
duration of pain may not be a good surrogate for severity.
Table 3: Likelihood ratios and odds ratios with 95% conﬁdence
intervals in the detection of visceral sources of pain with tests of
cutaneous allodynia, myofascial trigger points, and reduced pain
thresholds.
LR+ 95% C.I. OR 95% C.I.
Abdominal
cutaneous
allodynia
4.19 1.46, 12.0 10.41 2.72, 39.79
Perineal
cutaneous
allodynia
2.91 1.19, 7.11 5.93 1.76, 20.02
Abdominal
trigger points 4.19 1.46, 12.0 10.41 2.72, 39.79
Perineal trigger
points 1.35 0.86, 2.13 2.2 0.77, 6.13
Reduced pain
thresholds 1.14 0.85, 1.52 1.85 0.55, 6.30
LR+: likelihood of a positive test.
OR: odds ratio of a positive test.
95% C.I.: 95% conﬁdence interval.
Table 4: Mean pain thresholds in grams by region of the abdomen
among women with visceral and somatic causes of pelvic pain.
Diagnosis N Mean Std. deviation Std. error mean
Deltoid Visceral 62 100.0
Somatic 19 100.0
RUQ Visceral 62 98.2 8.6 1.1
Somatic 19 100.0
LUQ Visceral 62 98.6 8.3 1.1
Somatic 19 100.0
RLQ Visceral 62 75.8∗ 29.1 3.8
Somatic 19 91.5∗ 21.4 4.9
LLQ Visceral 62 78.2∗ 27.2 3.5
Somatic 19 93.3∗ 20.0 4.6
Perineum Visceral 62 69.9 25.6 3.2
Somatic 19 73.1 22.5 5.2
∗P<0.05. RUQ: right-upper quadrant of the abdomen. LUQ: left-upper
quadrantoftheabdomen.RLQ:right-lowerquadrantoftheabdomen.LLQ:
left-lower quadrant of the abdomen.
There are limitations to this preliminary evaluation. It
is based on the best available clinical judgment in relation
to preexisting and current conditions. As the tests were
undertaken by the clinician doing the assessments, there is a
possibility of bias in the interpretation of the test ﬁndings.
A study is now underway to explore these ﬁndings prior
to and following operative laparoscopy so that the actual
assessment of visceral disease may be concurrent with test
evaluation and not historical in nature. Future studies will
permit test blinding in relation to diagnostic allocation.
Preliminary ﬁndings of a blinded interrater reliability study
evaluating 50 women with and without pelvic pain indicate
98% agreement in the testing of cutaneous allodynia.
In this study an allocation to apparent visceral source
of pain was based on available documented history andPain Research and Treatment 5
operative notes. Women with apparent somatic sources of
pain included those with lower genital tract pelvic trauma.
A larger sample size will be required to explore the value of
these tests in relation to speciﬁc causes of visceral conditions
such as endometriosis and various somatic conditions. A
longitudinal study will be required to evaluate the develop-
mentalpatternsinvolved.Infuture,thepotentialrelationship
of the ﬁndings to speciﬁc therapeutics will be an important
consideration.
The tests are simple to perform, based upon validated
methods, and do not require sophisticated equipment. The
tests are readily accepted by women because of their simplic-
ity and potential ability to provide an acknowledgement of
theirpelvicpain.Withagreatersamplesizeandaprospective
evaluation, the relevance to the clinical diagnosis and the
relationship of test results to the longitudinal pattern of
disease over time may become clearer.
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